Biography: Proficient in all general endoscopic procedures including screening colonoscopies, allpolypectomy techniques, upper GI and colonic dilations (including CRE balloon and Savary),hemostasis of GI bleeds (variceal banding, sclerotherapy, clipping, bipolar cautery, APC), faecal microbiota transplant (FMT) and PEG placement and replacement.

Will have performed approximately 2,300 endoscopic procedures by December 2017.

Will have performed over 100 ERCPs by the end of December 2017.

Extensive clinical training in general GI including functional diseases, IBD and liver disease

Proficient in interpretation of small bowel capsule endoscopy, pH studies, breath testing and motility studies including high resolution esophageal and anorectal manometry.

Familiar with balloon and plate RFA techniques and use of VLE in Barrett’s ablations.

Familiar with push and single balloon enteroscopy Recipient of Residents as Educators (RAE) training program for clinical education Appointed member of ACGME Program Evaluation Committee (PEC).

Research Interet: screening colonoscopies, all polypectomy techniques, upper GI and colonic dilations (including CRE balloon and Savary), hemostasis of GI bleeds (variceal banding, sclerotherapy, clipping, bipolar cautery, APC), fecal microbiota transplant (FMT) and PEG placement and replacement, functional diseases, IBD and liver disease, Proficient in interpretation of small bowel capsule endoscopy.

I am a cancer biologist and proteomics researcher with more than ten years of experience in translational cancer research, radiation biology, liver diseases, and OMICS-based biomarker discovery. I am currently a Postdoctoral Fellow at the

department of MD Anderson, Integrated Services Unit (MDOISU), Cancer Research, South Texas Center of Excellence in Cancer Research (ST-CECR), The University of Texas Rio Grande Valley (UTRGV), where my research focuses on identifying molecular mechanisms and biomarkers associated with hepatocellular carcinoma (HCC), stress signaling, and long non-coding RNAs (lncRNAs), and Alzheimer disease (AD) using integrated proteomic and genomic approaches. I received my Ph.D. training at the Institute of Liver and Biliary Sciences (ILBS), New Delhi, and have held competitive postdoctoral and research positions at internationally recognized institutions, including The University of Texas MD Anderson Cancer Center, where I worked in the Department of Clinical Cancer Prevention. I was also awarded the National Post-Doctoral Fellowship (SERB-DST, Government of India) as Principal Investigator, leading an independent research project focused on proteomics-based identification of non-invasive biomarkers for drug-induced liver injury (DILI).

My expertise includes high-throughput LC-MS/MS proteomics (DIA-SWATH, TMT/iTRAQ labeling), biomarker validation, cancer cell biology, flow cytometry, and animal models, including xenograft and orthotopic mouse models. I have authored multiple peer-reviewed publications in high-impact journals such as Hepatology, Clinical Gastroenterology and Hepatology, Alimentary Pharmacology & Therapeutics, Cancers, Scientific Reports and Pharmacology Research, with over 700 citations. My research contributions have been recognized through several national and international awards, including the Young Investigator Award (APASL), Senior Investigator-in-Training Award (Radiation Research Society), and Best Poster Presentation Award (UTRGV).

My long-term research goal is to advance precision oncology and liver disease diagnostics by integrating proteomics and transcriptomics to identify clinically actionable biomarkers and therapeutic targets. My training, leadership as a funded investigator, and interdisciplinary expertise position me well to contribute meaningfully to NIH-funded translational and cancer health disparities research.

Research Interest(s):

• Radiation Biology.
• Liver & Colorectal Cancer.
• Liver Diseases, Liver in Drug Toxicity (Drug-induced liver injury, DILI).
• OMICS (Proteomics, Genomics, Metabolomics etc.).

URL of your official website: https://uthealthrgv.org

Dr. Li is currently a lecture in the School of Life Sciences at Anhui Medical University. She received her Ph.D. from University of Tasmania in Australia and followed by post-doctoral trainings in the First Affiliated Hospital of Anhui Medical University. Her lab focuses on understanding the mechanisms of innate immune cells, MAIT cells in the development of infectious diseases, sepsis-associated liver injury, and hepatocellular carcinoma. The current research concentrated on identifying targets for immunotherapy of infectious diseases, sepsis-associated liver injury, and hepatocellular carcinoma. In the past several years, he received several grants supporting, including from national and provincial natural science foundation of China

Research Interest: 

1. Immunological aspects and molecular pathogenesis of liver diseases
2. Liver regeneration, liver fibrosis and liver cancer
3. Novel therapeutic targets and new drug development of liver diseases

1. 2024: PhD in "Medical Science" at the PMU University of Salzburg (Austria) (currently enrolled in the 3nd year) coordinated by Prof. T. Casparri (duration 3 years)
2. From 2023: Adjunct Professor at the Università Cattolica del Sacro Cuore of Rome for the Infectious Diseases for Dental Hygienists course at the Claudiana School in Bolzano for a total of 13 hours of lectures and 10 hours of seminars (23 hours) 
3. 2020-2022: International Master in Dietetics and Clinical Nutrition obtained at Università Politecnica delle Marche (2 years) 
4. 30.11.2015: Master in Transplant Medicine and advanced Hepatology (MS) obtained  at Miland Medical School, North Italy under the supervision of Prof. M. Strazzabosco  (Yale University) (1 year) on “Hepatocellular carcinoma: retrospective analysis and  overall survival in BCLC-B patients of Regional Hospital of Bolzano”. 
5. 2015: Fellowship in Transplant Medicine and Advanced Hepatology at the Dept. of Gastroenterology, Hepatology and Liver Transplant Unit, Ospedale G. Paolo XXIII, Bergamo (Italy) under the supervision of Prof. S. Fagiuoli 
6. 16.11.2009: Ultrasound (Diploma Nazionale in Ecografia Clinica, SIUMB) Bolzano/Bozen, South Tyrol, ITALY 
7. 10.01.2005: Master in Hepatology obtained at Padua Medical School, University of Padua, North of Italy, under the supervision of Prof. L. Okolicsanyi (1 year) on “confronto tra angioecografia (CEUS) e tomografia assiale computerizzata (TAC) nella diagnostica delle lesioni epatiche focali: prime esperienze nel reparto di  Gastroenterologia dell´ospedale di Bolzano” Italian National Diploma in Clinical 
8. 2001-2016: Fellowships in Gastroenterology and Hepatology at the Universitätsklinik für Innere Medizin, Gastroenterologie und Hepatologie (Austria) under the supervision of Prof. W. Vogel and Prof. I. Graziadei (2001, 2005, 2006, 2007, 2010, 2011, 2012, 2013, 2016) 
9. December 2001: Completion of SPR training and completion of the National Qualifying Exam in Gastroenterology and Digestive Endoscopy, obtained at Padua Medical School, University of Padua, North of Italy 
10. NOTE: This is a four-year training scheme that involves annual clinical and written  exams and is recognised as equivalent to the British SpR training scheme in Gastroenterology under the European Law 93/16 on the 5th April 1993 and EU Directive 2005/36/EC 
11. May 1997: Completion of the Medical National Qualifying Exam in Medicine and \Surgery, obtained at Padua Medical School, University of Padua, North of Italy 
12. July 1996: MD thesis (points 70/70) on: "Bone Metabolism in Primary Biliary cirrhosis" under the supervision of Prof. R. Naccarato 

Current position:

From 02.02.04 to date Permanent position as Consultant Gastroenterologist at the Dept. Of Gastroenterology, San Maurizio Regional Hospital, Bolzano/Bozen, South Tyrol, ITALY

From 08.01.02 to 02.02.04 Consultant Gastroenterologist at the Dept. of Internal Medicine San Maurizio Regional Hospital, Bolzano/Bozen, South Tyrol, ITALY.

During this period, I participated on the on call rota in Internal Medicine (more than 60 beds), and was involved in the treatment of both inpatients and outpatients with gastroenterological, cardiological, endocrinological and diabetic disease.

Research Interest: Collection of data on hepatocellular carcinoma within the framework of the national working group ITALICA, which brings together the major national centres dealing with liver cancer pathology

Research projects on autoimmune liver diseases within the framework of the establishment of the national network of Autoimmune Liver Diseases

Research projects with the Paracelsus Medical University in Salzburg (Prof Elmar Aigner - Internal Medicine/Gastroenterology); Multicentre collaborative study on hepatic steatofibrosis in metabolic diseases and patients with diabetes mellitus treated with antidiabetic drugs

Study of residual liver function in hepatocarcinoma patients in surgical and locoregional HCC treatment